Overview

Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence.

Status:
Active, not recruiting

Trial end date:
2022-11-01

Target enrollment:

Participant gender:

Summary

The aim of this study is to evaluate the sentinel node policy in early stage endometrial carcinomas at intermediate and high risk of recurrence (by comparing the sentinel node policy to current initial staging protocols).

Phase:

Phase 3

Details

Lead Sponsor:

Centre Oscar Lambret

Collaborators:

Canceropôle Nord Ouest
Institut National de la Santé Et de la Recherche Médicale, France
National Cancer Institute, France